Related Experiment Video
Updated: May 7, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung
Kaori Koga1, Makoto Hamasaki, Fumiaki Kato
1Department of Pathology, Fukuoka University Hospital and School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.
Abstract:
Lung adenocarcinomas with micropapillary pattern (MPP) are associated with frequent nodal metastasis. However, little is known about the mechanisms that underlie MPP-associated nodal metastasis. We have previously reported that pT1 lung adenocarcinomas with MPP are significantly associated with small cluster invasion (SCI) and lymphatic involvement. SCI is defined as markedly resolved acinar-papillary tumor structures with single or small clusters of carcinoma cells invading stroma within fibrotic foci. In this study, we hypothesized that c-Met activation may be involved in the MPP-SCI sequence, given that the c-Met tyrosine-kinase receptor and its ligand hepatocyte growth factor (HGF), play important roles in tumor cell motility and invasion. We analyzed 125 pT1-size lung adenocarcinomas for immunohistochemical expression of phosphorylated c-Met and its correlation with MPP, SCI, lymphatic involvement and prognosis. SCI was significantly more frequent in the MPP-positive group (P<0.0001) and associated with lymphatic involvement (P<0.0001) and nodal metastasis (P=0.021). c-Met protein was detected in all tumors by immunohistochemistry as membranous and cytoplasmic staining. Phospho-c-Met (pc-Met) was positive in 119/125 tumors (95%) and expressed at high levels in 27 cases (22%). A high level of pc-Met expression was significantly associated with MPP (P=0.01) and SCI (P=0.0059). Moreover, in tumors with MPP or SCI, those expressing high levels of pc-Met were significantly more associated with lymphatic involvement. In p-Stage IA lung adenocarcinomas (n=99), patients in the high pc-Met expression group showed significantly worse survival than patient in the low expression group (P=0.0313). These results suggest that activation of c-Met through phosphorylation may be involved in MPP and SCI.
Insights
Micropapillary pattern in lung adenocarcinoma is linked to metastasis. This study suggests that activated c-Met signaling drives this process, potentially impacting patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Pathology
Background:
- Lung adenocarcinomas with micropapillary pattern (MPP) frequently metastasize to lymph nodes.
- The underlying mechanisms of MPP-associated metastasis, particularly small cluster invasion (SCI), remain unclear.
- The c-Met pathway is implicated in tumor cell motility and invasion.
Purpose of the Study:
- To investigate the role of c-Met activation in the sequence of MPP and SCI in lung adenocarcinoma.
- To correlate phosphorylated c-Met (pc-Met) expression with MPP, SCI, lymphatic involvement, and prognosis in pT1 lung adenocarcinomas.
Main Methods:
- Immunohistochemical analysis of phosphorylated c-Met (pc-Met) in 125 pT1 lung adenocarcinomas.
- Correlation of pc-Met expression with clinicopathological features including MPP, SCI, lymphatic involvement, and nodal metastasis.
- Survival analysis in relation to pc-Met expression levels.
Main Results:
- SCI was significantly more frequent in MPP-positive tumors and associated with lymphatic involvement and nodal metastasis.
- High pc-Met expression strongly correlated with MPP and SCI.
- In tumors with MPP or SCI, high pc-Met levels were linked to increased lymphatic involvement.
- High pc-Met expression predicted worse survival in Stage IA lung adenocarcinoma patients.
Conclusions:
- Activation of the c-Met pathway, indicated by high pc-Met expression, is associated with MPP and SCI in lung adenocarcinoma.
- The c-Met pathway may play a critical role in the progression and metastasis of lung adenocarcinomas with MPP.
- Targeting the c-Met pathway could be a potential therapeutic strategy for these tumors.
